14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for REGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 993.58 1.15 %
R2 987.25 0.505 %
R1 983.34 0.107 %
Current price: 982.29
Support S1 970.68 -1.18 %
S2 966.77 -1.58 %
S3 960.44 -2.22 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 993.35 1.13 %
R2 989.28 0.712 %
R1 987.61 0.542 %
Current price 982.29
Support S1 966.09 -1.65%
S2 964.47 -1.81%
S3 937.61 -4.55%

REGN Predictions History

3 years ago
JS predicted that REGN for 2020-07-08 is going $646.25 (0.92%)

3 years ago
Michael Tyler predicted that REGN for 2020-07-08 is going $644.69 (0.59%)

3 years ago
JS predicted that REGN for 2020-07-02 is going $604.57 (-2.87%)

3 years ago
Michael Tyler predicted that REGN for 2020-07-02 is going $605.85 (-2.67%)

3 years ago
JS predicted that REGN for 2020-07-01 is going $629.00 (3.26%)

3 years ago
Michael Tyler predicted that REGN for 2020-07-01 is going $626.02 (2.77%)

4 years ago
JS predicted that REGN for 2020-04-17 is going $545.85 (-4.03%)

4 years ago
2poJeff predicted that REGN for 2020-04-17 is going $534.98 (-0.92%)

4 years ago
JS predicted that REGN for 2020-04-01 is going $473.28 (-4.71%)

4 years ago
2poJeff predicted that REGN for 2020-04-01 is going $475.13 (-2.70%)

Click to get the best stock tips daily for free!

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlus... REGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT